Antiseptic Throat Lozenges Orange & Menthol

Country: Ireland

Bahasa: Inggeris

Sumber: HPRA (Health Products Regulatory Authority)

Bahan aktif:

Amylmetacresol

Boleh didapati daripada:

The Boots Company Plc

Kod ATC:

R02AA; R02AA20

INN (Nama Antarabangsa):

Amylmetacresol

Dos:

0.6 milligram(s)

Borang farmaseutikal:

Lozenge

Jenis preskripsi:

Product not subject to medical prescription

Kawasan terapeutik:

Antiseptics; various

Status kebenaran:

Not marketed

Tarikh kebenaran:

2001-05-17

Ciri produk

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Antiseptic Throat Lozenges Orange & Menthol
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Amylmetacresol
0.6 mg per lozenge
Excipients:
Sucrose 1.5g
Glucose 1.0g
For full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lozenge
Orange, circular lozenges.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the short-term symptomatic relief of sore throats.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and Children over 12 years: One throat lozenge to be sucked
when required, up to a maximum of 8 throat
lozenges in 24 hours.
Children 5-12 years: One throat lozenge to be sucked when required up
to a maximum of 4 throat lozenges in 24
hours.
The maximum dose at any one time is one throat lozenge.
Children under 5 years: Not suitable.
4.3 CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Keep all medicines out of the reach of children.
Do not exceed the stated dose.
If symptoms persist or worsen after 2-3 days see your doctor.
Information related specifically to the excipients in this formulation
(See Section 6.1).
Glucose: Each lozenge contains 1g glucose. This should be taken into
account by patients with diabetes mellitus.
Patients with rare glucose-galactose malabsorption should not take
this medicine.
Sucrose: Each lozenge contains 1.5g sucrose. This should be taken into
account by patients with diabetes mellitus.
Patients with rare hereditary problems of fructose intolerance,
glucose-galactose malabsorption or sucrose-isomaltase
insufficiency should not take this medicine.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__